What the Pharmaceutical, Biotech, and Device Industries Should Expect In 2025

The coming year will present unprecedented legal and policy challenges for the life sciences industry. To meet those challenges, please join us for a day-long, CLE-accredited program on the rapidly evolving legal and policy landscape. This program, presented by Arnold & Porter’s renowned life sciences practice, is intended for pharmaceutical, biotech, medical device, and diagnostic company in-house counsel and compliance personnel. Whether you are at an established or emerging company, we will help you prepare for the important regulatory, fraud and abuse, pricing, compliance, legislative, white collar, SEC, Supreme Court, antitrust, transactions, product liability, IP, and privacy developments that we anticipate next year and beyond.

We invite you to join the event and come with questions.